Renx Enterprises Corp. 8-K Summary
Business Context and Reporting Period
Renx Enterprises Corp. (Nasdaq: RENX) filed a Current Report on Form 8-K dated February 12, 2026, reporting the entry into a Material Definitive Agreement. The Company, an emerging growth company incorporated in Delaware, announced a private placement transaction that closed on February 17, 2026.
Key Financial Metrics and Transaction Details
- Principal Amount: $6,042,985.39 in Senior Convertible Notes.
- Net Proceeds: Approximately $5.4 million after deducting placement agent fees and offering expenses.
- Interest Rate: 12% per annum (increases to 18% per annum upon an event of default).
- Maturity: 13 months from the date of issuance.
- Conversion Price: $0.281 per share of Common Stock.
- Warrants Issued:
- First Warrants: 21,505,287 shares exercisable immediately at $0.15594 per share.
- Second Warrants: 17,246,704 shares exercisable only after Stockholder Approval at $0.15594 per share.
- Outstanding Shares: 46,360,994 shares of Common Stock as of February 13, 2026.
Material Changes and Terms
The Company entered into a Securities Purchase Agreement with institutional investors. Key terms include:
- Repayment Structure: Notes are payable in ten monthly installments of 110% of 1/10th of the principal plus accrued interest, commencing 180 days post-closing or 90 days after the registration statement is declared effective.
- Redemption: The Company may redeem Notes at any time at 110% of principal plus accrued interest. In the event of a default, holders may require redemption at a price based on the greater of 110% of value or a formula based on the stock price.
- Registration Rights: The Company must file a registration statement within 30 days of closing and use commercially reasonable efforts to have it declared effective within 45 days (or 75 days for a full review).
- Lock-up: Directors, officers, and 5% stockholders are locked up for 30 days after the effectiveness of the initial registration statement.
Guidance, Risks, and Contingencies
- Use of Proceeds: Net proceeds are intended for working capital purposes.
- Stockholder Approval Requirement: The Second Warrants (17.2 million shares) cannot be exercised until stockholder approval is obtained. The Company must hold a stockholder meeting no later than 90 days after the closing date. If approval is not obtained, additional meetings must be held every 90 days.
- Dilution Risk: Full conversion of Notes (including accrued interest) and exercise of all Warrants could result in the issuance of approximately 24.3 million shares from the Notes and 38.75 million shares from the Warrants, subject to beneficial ownership limitations (4.99% or 9.99%).
- Future Financing Restrictions: The Company is restricted from issuing equity or common stock equivalents for 30 trading days following the effectiveness of the registration statement. Additionally, purchasers have a right to participate in up to 50% of any subsequent financing for 12 months after the Notes are no longer outstanding.
- Liquidated Damages: The Company is obligated to pay liquidated damages if the registration statement is not filed or declared effective by the specified deadlines.
Investor Verification Checklist
- Verify the effectiveness date of the registration statement for resale of Conversion Shares and Warrant Shares.
- Monitor the timeline for the stockholder meeting required to approve the Second Warrants.
- Review the Company's cash position to assess its ability to meet the first installment payment due 180 days post-closing.
- Confirm the total number of shares outstanding post-conversion to evaluate potential dilution impact.
- Check for any subsequent financing announcements that may trigger the 50% participation right for purchasers.